<DOC>
	<DOCNO>NCT02271828</DOCNO>
	<brief_summary>STUDY AIM To decrease number breast cancer patient receive treatment axilla , order positively influence axillary morbidity rate quality life . PRIMARY OBJECTIVE To determine whether omit sentinel lymph node procedure inferior current axillary stag regimen clinically node negative breast cancer patient undergo breast conserving therapy , term regional recurrence rate . HYPOTHESIS The sentinel lymph node procedure safely omit clinically node negative breast cancer patient undergo breast conserve therapy . This lead decrease axillary morbidity rate , non-inferior regional recurrence- , distant-disease free- overall survival rate .</brief_summary>
	<brief_title>Omitting Sentinel Node Procedure Breast Cancer Patients Undergoing Breast Conserving Therapy</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Female Aged 18 year old Pathologically confirm invasive breast carcinoma A clinical T12 tumor Will treat lumpectomy whole breast radiotherapy Clinically node negative status : sign axillary lymph node metastases physical examination preoperative axillary ultrasound ( negative cyto/histopathology ) Written informed consent Clinically node positive preoperative Bilateral breast cancer Evidence metastatic disease History invasive breast cancer Previous treatment axilla surgery radiotherapy ( except surgery hidradenitis suppurativa superficially locate skin lesion , naevi ) Pregnant nursing Other prior malignancy within past 5 year ( except successfully treat basal cell squamous cell skin cancer , carcinoma situ cervix carcinoma situ ipsilateral contralateral breast ) unsuccessfully treated malignancy &gt; 5 year randomization Unable unwilling give inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>